Skills & Qualifications • Ability to work independently and efficiently. • Strong organizational and task prioritization skills. • Excellent communication skills and proficiency in performing administrative and clerical tasks. • Proficient in general laboratory procedures
techniques
and documentation. • Willingness to learn and adapt to new techniques and technologies. • Fluent in English
Spanish
French
and Catalan. • Proficient in statistical analysis and software such as SPSS
MATLAB
and Python. • Proficient in using various software programs
including Microsoft Office Suite (Word
Excel
PowerPoint). • Advanced knowledge and experience in 3D cell culture techniques. • Skilled in protein isolation
Western Blot
PCR
rt-qPCR
toxicity testing
IHC
Northern Blot
and ELISA. • Proficient in anatomical dissection studies for medical and veterinary purposes. • Experienced in static analysis of behavioral data and microarray data. • Familiarity with electrophysiology
imaging
protein purification
and optical and electron microscopy techniques. • Advanced level proficiency in conducting animal experiments
behavioral experiments
anatomical dissection
and molecular analysis. Education Uskudar University
M.Sc. September 2019-June
2022 Istanbul
Turkey Cumulative GPA:3.78 High Honor Student Master Science in Neuroscience Department of Neuroscience Sciences Thesis: Investigation of TopoII ß Gene Expression in LPS-Induced HMC3 Microglia Cell Line Pamukkale University
B.Sc. September2015-June 2019 Denizli
Turkey Cumulative GPA: 3.0 Honour Student Bachelor of Science in Physical Therapy and Rehabilitation Universitat de Barcelona September2018- June 2019 Barcelona
Spain International Student ERASMUS Study Abroad Program As a clinical academic I divide my time equally between clinical stroke care (at University College Hospital and The National Hospital for Neurology and Neurosurgery
Queen Square) and academic commitments at the Stroke Research Centre
UCL Institute of Neurology. My major research interest is in the clinical an pathophysiological implications of cerebral small vessel disease (the commonest known brain disorder). My focus is on intracranial (including intracerebral) haemorrhage
which is the most devastating type of stroke. I have expertise in observational studies and neuroimaging including magnetic resonance imaging (MRI). I lead a research programme including observational
genetic and neuroimaging studies of subarachnoid haemorrhage and intracerebral haemorrhage
with particular expertise in cerebral amyloid angiopathy. I was Chief Investigator for the Clinical Relevance of Microbleeds in Stroke (CROMIS-2) study: www.ucl.ac.uk/cromis-2 and the Geneticand Observational Subarachnoid Haemorrhage (GOSH) Study. I was Chief investigator for the Biomarkers in Cerebral Amyloid Angiopathy (BOCAA) at UCL. I was UK Chief investigator for a therapeutic trial of the monoclonal antibody Ponezumab in Cerebral Amyloid Angiopathy. In collaboration with Prof Peter Rothwell (Oxford) I am Co-Chief Investigator for a randomised controlled trial of blood pressure lowering after intracerebral haemorrhage (Prevention Of Hypertensive Injury to the Brain - Intracerebral haemorrhage: PROHIBIT-ICH) funded by the Stroke Association. I am Chief Investigator of the BHF-funded OPTIMAS (Optimal Timing of Anticoagulation in Stroke) trial
currently running at over 60 hospitals in the UK. I am lead for the Microbleeds International Collaborative Network (MICON). I am Principal Investigator for numerous collaborative National Institute of Health Research (NIHR)-funded stroke research studies and am Speciality Lead for Stroke in the NIHR Clinical Research Network: North Thames. I am a member of Trial Steering Committees for NIHR multi-centre studies including TICH-3(Tranexamic Acid in Intracerebral Haemorrhage)
R4VaD (Risks
Rates and Routes to Reduce Vascular Dementia)
LACI-2 (Lacunar Intervention) and Remote Ischaemic Conditioning After Stroke (RECAST-3)
Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST).